Results 211 to 220 of about 956,738 (330)
Observations on the Inheritance of Sickle-Cell Hemoglobin and Hemoglobin C1 [PDF]
Helen M. Ranney
openalex +1 more source
This study reveals a novel mechanism of resistance to DNA hypomethylating agents (HMAs) in acute myeloid leukemia (AML), and identifies all‐trans retinoic acid (ATRA) and tamibarotene (TAM) as potent agents that overcome HMA resistance by reactivating the interferon anticancer immune response. The findings offer promising therapeutic strategies for HMA‐
Xueqin Chen+18 more
wiley +1 more source
Chemotherapy without Blood Products for Treatment of Acute Myelogenous Leukemia in an Anemic Jehovah's Witness Patient. [PDF]
Altaf R+5 more
europepmc +1 more source
CALCULATION OF HEMOGLOBIN FROM BLOOD SPECIFIC GRAVITIES
Donald D. Van Slyke+5 more
openalex +1 more source
This study designs an injectable porous hydrogel (HMs/MBs/ADSCs) integrating hollow microspheres for sustained BMP‐2 release to enhance adipose‐derived stem cells' paracrine effect. It accelerates tendon‐bone healing in rat rotator cuff injuries via spatiotemporal regulation: early AMPK‐mediated mitochondrial protection and late TGF‐β/Smad2/3‐driven ...
Meijuan Yuan+11 more
wiley +1 more source
RATIO OF SICKLE-CELL ANEMIA HEMOGLOBIN TO NORMAL HEMOGLOBIN IN SICKLEMICS
Ibert C. Wells, Harvey A. Itano
openalex +1 more source
NUTRITIONAL EDEMA IN THE DOG. V. DEVELOPMENT OF DEFICITS IN ERYTHROCYTES AND HEMOGLOBIN ON A DIET DEFICIENT IN PROTEIN 1 [PDF]
A. A. Weech+2 more
openalex +1 more source
This study develops an a red/far‐red light‐controlled iPSC‐based vaccines (RIVA) based on the chimeric photosensory protein FnBphP and its interaction partner LDB3 for cancer immunotherapy. The RIVA preserves the multiple intrinsic tumor antigens of iPSCs and enables optogenetic control of the expression of the immune adjuvant type I interferon β under
Longliang Qiao+17 more
wiley +1 more source
Carbon Dioxide and Hemoglobin at Presentation with Hypertrophic Pyloric Stenosis-Are They Relevant? Cohort Study and Current Opinions. [PDF]
Tröbs RB+4 more
europepmc +1 more source